Archives

Loading Events

Factors Influencing Drug Dialyzability

Factors Influencing Drug Dialyzability

Background

Deciding when to administer a medication around chronic dialysis can be a complex process in the clinical setting. Dr George Bailie and Dr Nancy Mason will present information about the medication-related and dialysis-related factors that influence medication removal by hemodialysis and peritoneal dialysis. They will review medication information resources on this topic, and also present an approach to administration of medications when dialyzability data are limited.

Why Attend This Webinar?

  • In this webinar, we will review medication information resources and present an approach to administration of medications when dialyzability data are limited in the hemodialysis and peritoneal dialysis populations.
What You Will Learn 
  • Drug-related and dialysis-related factors that influence drug dialyzability
  • How drug removal by high-flux hemodialysis can be different from that by low-flux hemodialysis
  • The effects of ratios of systemic volume of distribution to dialysate volume in various peritoneal dialysis regimens on drug clearance
  • How to use drug information resources to find dialysis dosing recommendations or pharmacokinetic drug data
  • How to use a step-wise approach to determine the appropriate drug dosing time around dialysis

Featuring

George R. Bailie

George R. Bailie, PharmD, PhD

Partner

Renal Pharmacy Consultants, LLC*

George R. Bailie is a Partner in Renal Pharmacy Consultants, LLC which produces Dialysis of Drugs, and Emeritus Professor of Pharmacy at Albany College of Pharmacy & Health Sciences, Albany, NY. His research and practice interests have included pharmacokinetic studies of medications in hemodialysis and peritoneal dialysis, and evaluation of medication prescription patterns and outcomes in chronic kidney disease. He has been actively involved with many pharmacy and nephrology-related professional organizations. He was previously also a partner in Nephrology Pharmacy Associates, LLC.

Nancy A. Mason

Nancy A. Mason, PharmD

Partner

Renal Pharmacy Consultants, LLC*

Nancy A. Mason is a Partner in Renal Pharmacy Consultants, LLC which produces Dialysis of Drugs, and Clinical Professor Emerita of Pharmacy at the University of Michigan College of Pharmacy. Dr Mason’s primary clinical research and practice interests have focused on the care of dialysis patients. She has served as chair of the ACCP Nephrology Pharmacy Practice and Research Network and has worked with numerous other professional organizations including the National Kidney Foundation and the American Society of Nephrology. Her publications have focused on medication-related issues in patients with kidney disease, including pharmacokinetics of medications, medication-related problems, and medication reconciliation in dialysis patients. She was previously also a partner in Nephrology Pharmacy Associates, LLC.

Jaimini Patel

Jaimini Patel, PharmD, BCCCP

Nephrology Clinical & Scientific Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Jaimini Patel, PharmD, BCCCP, is a Nephrology Clinical and Scientific Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Patel earned her Doctorate in Pharmacy from the University of Michigan, Ann Arbor and completed two years of post-doctoral residency at Beaumont Hospital, Royal Oak and Loyola University Medical Center, respectively, specializing in critical care pharmacy practice. Prior to joining Otsuka, Dr Patel practiced as a critical care pharmacist at the Cleveland Clinic Akron General Medical Center for 3.5 years and has cared for patients in the medical, surgical/trauma, cardiothoracic and neuroscience ICUs, and was significantly involved in the care of patients with COVID-19. Dr Patel holds board certification in critical care pharmacotherapy and is a licensed pharmacist in Michigan, Illinois and Ohio. She is also an active member of the Society of Critical Care Medicine through which she is engaged in research and leadership.

*Drs Bailie and Mason are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Patel is an employee of OPDC.

Registration

Related Resources